Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Breast cancer

  • You have access
    SHP-1 acts as a tumor suppressor by interacting with EGFR and predicts the prognosis of human breast cancer
    Qian Geng, Ruiting Xian, Yinjue Yu, Fengsheng Chen and Rong Li
    Cancer Biology & Medicine April 2022, 19 (4) 468-485; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0501
  • You have access
    The biogenesis, function and clinical significance of circular RNAs in breast cancer
    Yan Zeng, Yutian Zou, Guanfeng Gao, Shaoquan Zheng, Song Wu, Xiaoming Xie and Hailin Tang
    Cancer Biology & Medicine January 2022, 19 (1) 14-29; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0485
  • You have access
    Current research on circular RNAs and their potential clinical implications in breast cancer
    Diya Liu and Lin Fang
    Cancer Biology & Medicine August 2021, 18 (3) 635-648; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0275
  • You have access
    Anlotinib has good efficacy and low toxicity: a phase II study of anlotinib in pre-treated HER-2 negative metastatic breast cancer
    Nanlin Hu, Yiran Si, Jian Yue, Tingting Sun, Xue Wang, Zhuqing Jia, Songlin Gao, Qiao Li, Yang Shao, Jiayu Wang, Yang Luo, Fei Ma, Binghe Xu and Peng Yuan
    Cancer Biology & Medicine August 2021, 18 (3) 849-859; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0463
  • You have access
    Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030
    Shaoyuan Lei, Rongshou Zheng, Siwei Zhang, Ru Chen, Shaoming Wang, Kexin Sun, Hongmei Zeng, Wenqiang Wei and Jie He
    Cancer Biology & Medicine August 2021, 18 (3) 900-909; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0523
  • You have access
    BRCA mutation rate and characteristics of prostate tumor in breast and ovarian cancer families: analysis of 6,591 Italian pedigrees
    Laura Cortesi, Federica Domati, Annalisa Guida, Isabella Marchi, Angela Toss, Elena Barbieri, Luigi Marcheselli, Marta Venturelli, Simonetta Piana, Claudia Cirilli and Massimo Federico
    Cancer Biology & Medicine May 2021, 18 (2) 470-476; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0481
  • You have access
    VEGFR2 inhibition hampers breast cancer cell proliferation via enhanced mitochondrial biogenesis
    Hao Ni, Min Guo, Xuepei Zhang, Lei Jiang, Shuai Tan, Juan Yuan, HuanhuanL Cui, Yanan Min, Junhao Zhang, Susanne Schlisio, Chunhong Ma, Wangjun Liao, Monica Nister, Chunlin Chen, Shuijie Li and Nailin Li
    Cancer Biology & Medicine February 2021, 18 (1) 139-154; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0151
  • You have access
    Drug resistance gene expression and chemotherapy sensitivity detection in Chinese women with different molecular subtypes of breast cancer
    Jing Zhao, Hailian Zhang, Ting Lei, Juntian Liu, Shichao Zhang, Nan Wu, Bo Sun and Meng Wang
    Cancer Biology & Medicine November 2020, 17 (4) 1014-1025; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0157
  • You have access
    Role of chromosomal instability and clonal heterogeneity in the therapy response of breast cancer cell lines
    Natalia Vargas-Rondón, Erika Pérez-Mora, Victoria E. Villegas and Milena Rondón-Lagos
    Cancer Biology & Medicine November 2020, 17 (4) 970-985; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0028
  • You have access
    SHP2 promotes proliferation of breast cancer cells through regulating Cyclin D1 stability via the PI3K/AKT/GSK3β signaling pathway
    Yue Yuan, Yanling Fan, Zicong Gao, Xuan Sun, He Zhang, Zhiyong Wang, Yanfen Cui, Weijie Song, Zhaosong Wang, Fei Zhang and Ruifang Niu
    Cancer Biology & Medicine August 2020, 17 (3) 707-725; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0056

Pages

  • Previous
  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2026 Cancer Biology & Medicine

Powered by HighWire